Non contraceptive health benefits of intrauterine devices: A systematic review

被引:106
作者
Hubacher, D
Grimes, DA
机构
[1] Family Hlth Int, VP Biomed Affairs, Res Triangle Pk, NC 27709 USA
[2] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA
关键词
D O I
10.1097/00006254-200202000-00024
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Most women and their clinicians are unaware that IUDs confer important noncontraceptive health benefits. This review summarizes the evidence from published articles on this topic. We conducted a series of systematic literature searches to identify articles on the noncontraceptive health benefits of IUD use. We reviewed the potentially pertinent ones for content, grouped them according to type of IUD, and evaluated them using the U.S. Preventive Services Task Force rating system. Over 500 titles were identified and several hundred abstracts were reviewed. Use of nonhormonal IUDs (plastic and copper) was associated with a decrease in endometrial cancer. The levonorgestrel intrauterine system can treat a variety of gynecological disorders, including menorrhagia and anemia. The levonorgestrel system has also been used successfully as part of hormone replacement therapy, as adjuvant therapy with tamoxifen, and as an alternative to hysterectomy for women with bleeding problems. Like oral contraceptives, intrauterine contraceptives confer important noncontraceptive health benefits. Target Audience: Obstetricians & Gynecologists, Family Physicians Learning Objectives: After completion of this article, the reader will be able to describe the currently marketed IUDs in the U.S., to summarize the current literature about the non contraceptive benefits of IUD use, and to list the noncontraceptive benefits of IUD use.
引用
收藏
页码:120 / 128
页数:9
相关论文
共 73 条
[1]   LEVONORGESTREL-RELEASING INTRAUTERINE-DEVICE IN THE TREATMENT OF MENORRHAGIA [J].
ANDERSSON, JK ;
RYBO, G .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (08) :690-694
[2]  
ANDERSSON K, 1992, OBSTET GYNECOL, V79, P963
[3]   LEVONORGESTREL-RELEASING AND COPPER-RELEASING (NOVA T) IUDS DURING 5 YEARS OF USE - A RANDOMIZED COMPARATIVE TRIAL [J].
ANDERSSON, K ;
ODLIND, V ;
RYBO, G .
CONTRACEPTION, 1994, 49 (01) :56-72
[4]   The levonorgestrel intrauterine system in the management of menorrhagia [J].
Barrington, JW ;
BowenSimpkins, P .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (05) :614-616
[6]   INTRAUTERINE CONTRACEPTION AND THE RISK OF ENDOMETRIAL CANCER [J].
CASTELLSAGUE, X ;
THOMPSON, WD ;
DUBROW, R .
INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (06) :911-916
[7]  
Cheng D, 2000, SOUTHERN MED J, V93, P859
[8]   The Levonorgestrel-releasing intrauterine device: A wider role than contraception [J].
Coleman, M ;
McCowan, L ;
Farquhar, C .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1997, 37 (02) :195-201
[9]   Systematic reviews: Synthesis of best evidence for clinical decisions [J].
Cook, DJ ;
Mulrow, CD ;
Haynes, RB .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (05) :376-380
[10]   Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding [J].
Crosignani, PG ;
Vercellini, P ;
Mosconi, P ;
Oldani, S ;
Cortesi, I ;
DeGiorgi, O .
OBSTETRICS AND GYNECOLOGY, 1997, 90 (02) :257-263